FDA approves marketing of first AI device to detect diabetic eye disease

      Source: Xinhua| 2018-04-12 02:23:42|Editor: Shi Yinglun
      Video PlayerClose

      WASHINGTON, April 11 (Xinhua) -- The United States Food and Drug Administration (FDA) permitted on Wednesday the marketing of the first medical device to use artificial intelligence to detect greater than a mild level of the eye disease diabetic retinopathy in adults who have diabetes.

      Diabetic retinopathy, the most common cause of vision loss for people living with diabetes, occurs when high levels of blood sugar lead to damage in the blood vessels of the retina, the light-sensitive tissue in the back of the eye.

      "Early detection of retinopathy is an important part of managing care for the millions of people with diabetes, yet many patients with diabetes are not adequately screened for diabetic retinopathy since about 50 percent of them do not see their eye doctor on a yearly basis," said Malvina Eydelman, M.D., director of the Division of Ophthalmic, and Ear, Nose and Throat Devices at the FDA's Center for Devices and Radiological Health.

      "Today's decision permits the marketing of a novel artificial intelligence technology that can be used in a primary care doctor's office," Eydelman said.

      The device, called IDx-DR, is a software program that uses an artificial intelligence algorithm to analyze images of the eye taken with a retinal camera called the Topcon NW400, according to FDA.

      A doctor uploads the digital images of the patient's retinas to a cloud server on which IDx-DR software is installed. If the images are of sufficient quality, the software provides the doctor with one of two results, either "more than mild diabetic retinopathy detected: refer to an eye care professional" or "negative for more than mild diabetic retinopathy: rescreen in 12 months."

      IDx-DR is the first device authorized for marketing that provides a screening decision without the need for a clinician to also interpret the image or results, which makes it usable by health care providers who may not normally be involved in eye care.

      The FDA evaluated data from a clinical study of retinal images obtained from 900 patients with diabetes at 10 primary care sites.

      In the study, IDx-DR was able to correctly identify the presence of more than mild diabetic retinopathy 87.4 percent of the time and was able to correctly identify those patients who did not have more than mild diabetic retinopathy 89.5 percent of the time.

      TOP STORIES
      EDITOR’S CHOICE
      MOST VIEWED
      EXPLORE XINHUANET
      010020070750000000000000011100001371042881
      主站蜘蛛池模板: 超级乱淫视频播放日韩| japanese成熟丰满熟妇| 欧美牲交a欧美牲交aⅴ免费下载| 国产99精华液| 亚洲成年www| 天堂精品高清1区2区3区| 久久中文骚妇内射| 欧美夫妇交换完整版随便看| 动漫精品专区一区二区三区不卡| 久久福利视频导航| 在线播放国产不卡免费视频| 中文字幕侵犯一色桃子视频| 李老汉的性生生活2| 亚洲网站www| 精品视频中文字幕| 国产在线无码视频一区 | 理论片高清免费理论片| 国产一区二区精品久久凹凸| 亚洲精品你懂的| 國产一二三内射在线看片| 三级黄色片在线观看| 日韩在线看片免费人成视频播放| 亚洲欧美日韩中文字幕在线| 精品久久久久国产| 国产一区二区三区精品视频| 国产私拍福利精品视频网站| 国产香蕉尹人综合在线观看| 一个人看的www日本高清视频| 日本三级香港三级人妇m| 亚洲av无码专区在线| 欧美激情在线精品video| 免费一级国产大片| 美女脱精光给男生摸| 国产午夜精品一区理论片| 日本在线高清视频| 国产高清免费在线观看| jizzyou中国少妇| 性欧美黑人巨大| 久久久xxxx| 日韩三级中文字幕| 亚洲AV色吊丝无码|